Singular Health Group (ASX:SHG) Piotroski F-Score: 4 (As of Jul. 01, 2026) — Near Median


ASX:SHG Singular Health Group Ltd ASX:SHG
30 GF Score
Price A$0.22
GF Value A$0.11
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Singular Health Group Piotroski F-Score?

Singular Health Group ASX:SHG +15.79% 30 Piotroski F-Score is 4 as of Jul. 01, 2026, which is at its 10-year median of 4.00. GuruFocus rates ASX:SHG with a GF Score™ of 30/100 and a GF Value™ of A$0.11 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 650 Healthcare Providers & Services companies, Singular Health Group ranks worse than 67.38% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Singular Health Group has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Singular Health Group's Piotroski F-Score or its related term are showing as below:

ASX:SHG' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 5
Current: 4

During the past 5 years, the highest Piotroski F-Score of Singular Health Group was 5. The lowest was 2. And the median was 4.

Singular Health Group  (ASX:SHG) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Singular Health Group Piotroski F-Score Related Terms


Singular Health Group Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Singular Health Group's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singular Health Group Piotroski F-Score Chart

Singular Health Group Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Piotroski F-Score
N/A N/A 2.00 5.00 4.00

Singular Health Group Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 5.00 0.00 4.00 0.00

ASX:SHG vs VEEV, BTSG, TEM: Piotroski F-Score Comparison

For the Health Information Services subindustry, Singular Health Group's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Singular Health Group Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singular Health Group's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Singular Health Group's Piotroski F-Score falls into.


ASX:SHG
30GF Score
Singular Health Group Ltd ASX:SHG
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun25) TTM:Last Year (Jun24) TTM:
Net Income was A$-6.38 Mil.
Cash Flow from Operations was A$-2.34 Mil.
Revenue was A$0.20 Mil.
Gross Profit was A$0.20 Mil.
Average Total Assets from the begining of this year (Jun24)
to the end of this year (Jun25) was (2.351 + 14.208) / 2 = A$8.2795 Mil.
Total Assets at the begining of this year (Jun24) was A$2.35 Mil.
Long-Term Debt & Capital Lease Obligation was A$0.00 Mil.
Total Current Assets was A$14.07 Mil.
Total Current Liabilities was A$1.11 Mil.
Net Income was A$-4.93 Mil.

Revenue was A$0.09 Mil.
Gross Profit was A$0.09 Mil.
Average Total Assets from the begining of last year (Jun23)
to the end of last year (Jun24) was (3.197 + 2.351) / 2 = A$2.774 Mil.
Total Assets at the begining of last year (Jun23) was A$3.20 Mil.
Long-Term Debt & Capital Lease Obligation was A$0.00 Mil.
Total Current Assets was A$2.20 Mil.
Total Current Liabilities was A$0.91 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Singular Health Group's current Net Income (TTM) was -6.38. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Singular Health Group's current Cash Flow from Operations (TTM) was -2.34. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun24)
=-6.376/2.351
=-2.71203743

ROA (Last Year)=Net Income/Total Assets (Jun23)
=-4.925/3.197
=-1.54050673

Singular Health Group's return on assets of this year was -2.71203743. Singular Health Group's return on assets of last year was -1.54050673. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Singular Health Group's current Net Income (TTM) was -6.38. Singular Health Group's current Cash Flow from Operations (TTM) was -2.34. ==> -2.34 > -6.38 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=0/8.2795
=0

Gearing (Last Year: Jun24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun23 to Jun24
=0/2.774
=0

Singular Health Group's gearing of this year was 0. Singular Health Group's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun25)=Total Current Assets/Total Current Liabilities
=14.065/1.111
=12.65976598

Current Ratio (Last Year: Jun24)=Total Current Assets/Total Current Liabilities
=2.199/0.91
=2.41648352

Singular Health Group's current ratio of this year was 12.65976598. Singular Health Group's current ratio of last year was 2.41648352. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Singular Health Group's number of shares in issue this year was 237.045. Singular Health Group's number of shares in issue last year was 160.146. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.203/0.203
=1

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.091/0.091
=1

Singular Health Group's gross margin of this year was 1. Singular Health Group's gross margin of last year was 1. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun24)
=0.203/2.351
=0.08634624

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun23)
=0.091/3.197
=0.02846419

Singular Health Group's asset turnover of this year was 0.08634624. Singular Health Group's asset turnover of last year was 0.02846419. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+1+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Singular Health Group has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Singular Health Group (ASX:SHG) has a Piotroski F-Score of 4 as of Jul. 01, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Singular Health Group and its competitors. This is near median its historical median of 4.00. Over the past decade, Singular Health Group's Piotroski F-Score has ranged from 2.00 to 5.00. According to the industry distribution chart, Singular Health Group ranks #438 out of 650 companies in the Healthcare Providers & Services industry, placing it in the top 67.4%.
Is Singular Health Group's Piotroski F-Score too high?
Singular Health Group's current Piotroski F-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 5.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Singular Health Group's value of 4 is 20% below this industry median. Based on the distribution chart, Singular Health Group ranks #438 out of 650 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Singular Health Group has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Singular Health Group's Piotroski F-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Singular Health Group ranks #438 out of 650 companies for Piotroski F-Score. This places Singular Health Group in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Singular Health Group's value of 4 is 20% below this benchmark. Historically, Singular Health Group's own Piotroski F-Score has ranged from 2.00 to 5.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Singular Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 650 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Singular Health Group's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Singular Health Group and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singular Health Group's current Piotroski F-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singular Health Group stock overvalued right now?
Based on GuruFocus' analysis, Singular Health Group (ASX:SHG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.11, compared to a current price of A$0.22 — trading 100% above its estimated fair value. The current Piotroski F-Score is 4, which is near median its 10-year median of 4.00 and 20% below the Healthcare Providers & Services industry median of 5.00. Singular Health Group's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Singular Health Group (ASX:SHG), the current Piotroski F-Score is 4 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Singular Health Group (ASX:SHG) Overvalued in 2026?

Based on GuruFocus' analysis, Singular Health Group stock appears to be overvalued. The current stock price of A$0.22 is trading 100% above its estimated GF Value™ of A$0.11. GuruFocus considers Singular Health Group to be Significantly Overvalued.

Key valuation signals for ASX:SHG:

  • Piotroski F-Score: 4 (near median its 10-year median of 4.00)
  • GF Value™: A$0.11 vs. price of A$0.22 (100% above fair value)
  • GF Score™: 30/100 with 2 warning signs
  • Industry Position: 20% below the Healthcare Providers & Services median (#438 of 650)

No single metric tells the full story. See the ASX:SHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Singular Health Group Business Description

Address E3 and E4, 661 Newcastle Street, Leederville, WA, AUS, 6007
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
30GF Score

Get the complete analysis for ASX:SHG

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.22
Price
A$0.11
GF Value